Patent | Date |
---|
Predicting productivity in early cell line development Grant 10,913,985 - Jamnikar , et al. February 9, 2 | 2021-02-09 |
Predicting genetically stable recombinant protein production in early cell line development Grant 10,913,984 - Jamnikar , et al. February 9, 2 | 2021-02-09 |
Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists App 20200163882 - Grahek; Rok ;   et al. | 2020-05-28 |
Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient Grant 10,357,431 - Staric , et al. July 23, 2 | 2019-07-23 |
Processes for preparing dolutegravir and cabotegravir and analogues thereof Grant 10,335,394 - Maras , et al. | 2019-07-02 |
Crystalline hydrates of 1-(.beta.-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethy- l]benzene Grant 10,323,056 - Selic , et al. | 2019-06-18 |
Cell culture medium and process for controlling .alpha.-amidation and/or C-terminal amino acid cleavage of polypeptides Grant 10,196,601 - Trcek Fe | 2019-02-05 |
Hydrates of dolutegravir sodium Grant 10,189,860 - Hotter , et al. Ja | 2019-01-29 |
Processes for the preparation of beta-aminosulfone compounds Grant 9,944,599 - Stavber , et al. April 17, 2 | 2018-04-17 |
Coated particles and pharmaceutical dosage forms Grant 9,907,757 - Humar , et al. March 6, 2 | 2018-03-06 |
Processes for Preparing Dolutegravir and Cabotegravir and Analogues Thereof App 20170368040 - Maras; Nenad ;   et al. | 2017-12-28 |
Predicting Productivity In Early Cell Line Development App 20170321288 - Jamnikar; Uros ;   et al. | 2017-11-09 |
Predicting Genetically Stable Recombinant Protein Production In Early Cell Line Development App 20170314082 - Jamnikar; Uros ;   et al. | 2017-11-02 |
Spray-Freeze Drying of Polyelectrolyte Nanoparticles Containing the Protein Drug App 20170258726 - CEGNAR; Mateja ;   et al. | 2017-09-14 |
1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline form Grant 9,732,053 - Hotter , et al. August 15, 2 | 2017-08-15 |
Novel Hydrates Of Dolutegravir Sodium App 20170217987 - Hotter; Andreas ;   et al. | 2017-08-03 |
Pharmaceutical composition Grant 9,707,178 - Avanzo , et al. July 18, 2 | 2017-07-18 |
Processes For The Preparation Of Beta-Aminosulfone Compounds App 20170174627 - Stavber; Gaj ;   et al. | 2017-06-22 |
Reduction of formation of amidated amino acids in cell lines for protein expression Grant 9,637,769 - {hacek over (S)}kulj , et al. May 2, 2 | 2017-05-02 |
Pharmaceutical composition Grant 9,622,976 - Beso , et al. April 18, 2 | 2017-04-18 |
Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content Grant 9,562,082 - Ficko Trcek February 7, 2 | 2017-02-07 |
Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives Grant 9,512,097 - Richter , et al. December 6, 2 | 2016-12-06 |
Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists App 20160346207 - Grahek; Rok ;   et al. | 2016-12-01 |
Selection of triploid CHO cells and cell lines expressing recombinant polypeptides as high producers Grant 9,499,857 - Obrstar November 22, 2 | 2016-11-22 |
Process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine Grant 9,493,409 - Zupancic November 15, 2 | 2016-11-15 |
Synthesis of triazolopyrimidine compounds Grant 9,469,614 - Zupancic , et al. October 18, 2 | 2016-10-18 |
1-[2-(2,4-dimethylphenylsulfanyl) Phenyl]piperazine Acetate In Crystalline Form App 20160289202 - HOTTER; Andreas ;   et al. | 2016-10-06 |
Oxidative degradation products of atrovastatin calcium Grant 9,453,030 - Grahek , et al. September 27, 2 | 2016-09-27 |
Method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins Grant 9,447,188 - Koncilja , et al. September 20, 2 | 2016-09-20 |
Production of glycoproteins with low N-glycolylneuraminic acid (NEU5GC) content Grant 9,428,562 - Ficko Trcek August 30, 2 | 2016-08-30 |
CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING a-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDES App 20160201028 - TRCEK; Tanja FICKO | 2016-07-14 |
Synthetic route for the preparation of .beta.-aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha ]pyrazin-7-yl compounds Grant 9,388,188 - Starcevic , et al. July 12, 2 | 2016-07-12 |
Enzymatic Route For The Preparation Of Chiral Gamma-Aryl-Beta-Aminobutyric Acid Derivatives App 20160194680 - STARCEVIC; Stefan ;   et al. | 2016-07-07 |
Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof Grant 9,376,397 - Casar , et al. June 28, 2 | 2016-06-28 |
Mammalian expression vector Grant 9,359,617 - Francky , et al. June 7, 2 | 2016-06-07 |
Preparation of sitagliptin intermediates Grant 9,359,385 - Casar , et al. June 7, 2 | 2016-06-07 |
Novel Crystalline Hydrates of 1-(Beta-D-Glucopyranosyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2-Thienylmethyl]- Benzene App 20160145286 - Selic; Lovro ;   et al. | 2016-05-26 |
Coated Particles And Pharmaceutical Dosage Forms App 20160128946 - Humar; Vlasta ;   et al. | 2016-05-12 |
Synthetic route for the preparation of .alpha.-amino boronic acid derivatives via substituted alk-1-ynes Grant 9,315,525 - Gazic Smilovic , et al. April 19, 2 | 2016-04-19 |
Ticagrelor adducts with divalent metal salts Grant 9,284,320 - Zupancic March 15, 2 | 2016-03-15 |
Synthesis of triazolopyrimidine compounds Grant 9,278,972 - Maras , et al. March 8, 2 | 2016-03-08 |
New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)Piperazine App 20160060215 - Zupancic; Borut | 2016-03-03 |
Synthesis of triazolopyrimidine compounds Grant 9,221,829 - Maras , et al. December 29, 2 | 2015-12-29 |
Synthesis of intermediates for preparing anacetrapib and derivatives thereof Grant 9,212,118 - Humljan , et al. December 15, 2 | 2015-12-15 |
Preparation of sitagliptin intermediates Grant 9,174,930 - Sova , et al. November 3, 2 | 2015-11-03 |
Coated particles and pharmaceutical dosage forms Grant 9,149,460 - Humar , et al. October 6, 2 | 2015-10-06 |
Process for preparing amorphous rosuvastatin calcium of impurities Grant 9,150,518 - Zlicar , et al. October 6, 2 | 2015-10-06 |
Process for the preparation of a pharmaceutical composition comprising ezetimibe Grant 9,089,486 - Kerc , et al. July 28, 2 | 2015-07-28 |
Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof Grant 9,085,538 - Casar , et al. July 21, 2 | 2015-07-21 |
Ticagrelor Adducts With Divalent Metal Salts App 20150191475 - Zupancic; Borut | 2015-07-09 |
Processes for the preparation of key intermediate for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof Grant 9,067,895 - Andrensek , et al. June 30, 2 | 2015-06-30 |
New Synthetic Route For The Preparation Of Beta-aminobutyryl Substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]Pyrazin-7-yl Compounds App 20150148533 - Starcevic; Stefan ;   et al. | 2015-05-28 |
Key Intermediates For The Synthesis Of Rosuvastatin Or Pharmaceutically Acceptable Salts Thereof App 20150141449 - CASAR; Zdenko ;   et al. | 2015-05-21 |
Oxidative Degradation Products Of Atrovastatin Calcium App 20150105551 - GRAHEK; Rok ;   et al. | 2015-04-16 |
Reduction Of Formation Of Amidated Amino Acids In Cell Lines For Protein Expression App 20150079634 - Skulj; Mihaela ;   et al. | 2015-03-19 |
Process for preparation of tacrolimus Grant 8,980,585 - Petkovic , et al. March 17, 2 | 2015-03-17 |
Synthesis of Triazolopyrimidine Compounds App 20150005498 - Maras; Nened ;   et al. | 2015-01-01 |
Synthesis of Triazolopyrimidine Compounds App 20140371449 - Maras; Nenad ;   et al. | 2014-12-18 |
Process for the preparation of enantiomerically enriched proton pump inhibitors Grant 8,889,873 - Mohar , et al. November 18, 2 | 2014-11-18 |
Production Of Glycoproteins With Low N-glycolylneuraminic Acid (neu5gc) Content App 20140288281 - FICKO TRCEK; Tanja | 2014-09-25 |
Production Of Glycoproteins With Low N-glycolylneuraminic Acid (neu5gc) Content App 20140255989 - FICKO TRCEK; Tanja | 2014-09-11 |
Synthesis of Triazolopyrimidine Compounds App 20140256747 - Zupancic; Borut ;   et al. | 2014-09-11 |
Pharmaceutical Composition Comprising Fesoterodine App 20140248351 - Cesar; Sara ;   et al. | 2014-09-04 |
Preparation Of Sitagliptin Intermediates App 20140213810 - Sova; Matej ;   et al. | 2014-07-31 |
Process for hydrogenation of halogenoalkenes without dehalogenation Grant 8,785,674 - Gazic Smilovic , et al. July 22, 2 | 2014-07-22 |
Preparation Of Sitagliptin Intermediates App 20140187558 - Casar; Zdenko ;   et al. | 2014-07-03 |
Methods of synthesis of .beta.-aminobutyryl substituted compounds Grant 8,765,668 - Sterk , et al. July 1, 2 | 2014-07-01 |
Pharmaceutical compositions comprising a combination of metformin and sitagliptin Grant 8,758,815 - Smrdel , et al. June 24, 2 | 2014-06-24 |
Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media Grant 8,753,681 - Legen , et al. June 17, 2 | 2014-06-17 |
Production of glycoproteins with low N-glycolylneuraminic acid (NEU5GC) content Grant 8,728,816 - Trcek May 20, 2 | 2014-05-20 |
Pharmaceutical Composition App 20140134247 - Beso; Adnan ;   et al. | 2014-05-15 |
Synthesis Of Intermediates For Preparing Anacetrapib And Derivatives Thereof App 20140135368 - Humljan; Jan ;   et al. | 2014-05-15 |
Crystal form of sunitinib malate Grant 8,703,967 - Selic April 22, 2 | 2014-04-22 |
Short synthesis of tolterodin, intermediates and metabolites Grant 8,703,996 - Sterk April 22, 2 | 2014-04-22 |
Salts of sunitinib Grant 8,686,023 - Selic April 1, 2 | 2014-04-01 |
Pharmaceutical composition Grant 8,685,452 - Beso , et al. April 1, 2 | 2014-04-01 |
Method for Controlling the Main Complex N-Glycan Structures and the Acidic Variants and Variability in Bioprocesses Producing Recombinant Proteins App 20140087423 - Koncilja; Matjaz ;   et al. | 2014-03-27 |
Process For The Preparation Of Key Intermediates For The Synthesis Of Statins Or Pharmaceutically Acceptable Salts Thereof App 20140051854 - Casar; Zdenko ;   et al. | 2014-02-20 |
Pharmaceutical Composition Comprising A Thiazolidinedione App 20140044783 - Stanic Ljubin; Tijana ;   et al. | 2014-02-13 |
Stable pharmaceutical composition comprising erythropoietin Grant 8,648,175 - Vukmirovic , et al. February 11, 2 | 2014-02-11 |
Coated formulations for tolterodine Grant 8,642,078 - Legen , et al. February 4, 2 | 2014-02-04 |
Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium Grant 8,614,331 - Mandic December 24, 2 | 2013-12-24 |
Process For The Preparation Of A Pharmaceutical Composition Comprising A Low Soluble Pharmaceutically Active Ingredient App 20130338131 - Staric; Rok ;   et al. | 2013-12-19 |
Enzymatic Synthesis Of Active Pharmaceutical Ingredient And Intermediates Thereof App 20130337485 - Mrak; Peter ;   et al. | 2013-12-19 |
Salts of O-desmethyl-venlafaxine Grant 8,604,194 - Borut , et al. December 10, 2 | 2013-12-10 |
Process For The Preparation Of 3-aroyl-5-aminobenzofuran Derivatives App 20130317100 - Richter; Frank ;   et al. | 2013-11-28 |
Self-microemulsifying drug delivery systems Grant 8,592,490 - Legen , et al. November 26, 2 | 2013-11-26 |
Process for the preparation or purification of olmesartan medoxomil Grant 8,592,474 - Pirc , et al. November 26, 2 | 2013-11-26 |
Nuclear Dna Content Of Cho Cell Lines As A Selection Criterion In Screening Of The Best Recombinant Protein Producers App 20130302816 - Obrstar; Darja | 2013-11-14 |
Surfactant-free stable pharmaceutical composition comprising granulocyte-colony stimulating factor Grant 8,580,246 - Podobnik , et al. November 12, 2 | 2013-11-12 |
Pharmaceutical Compositions Comprising Glimepiride And Polyethylene Glycol Castor Oil App 20130259935 - Jaklic; Miha ;   et al. | 2013-10-03 |
Coating Of Particles Comprising A Pharmaceutically Active Ingredient With A Carbonate Salt Or Phosphate Salt App 20130202713 - Bele; Marjan ;   et al. | 2013-08-08 |
Short Synthesis Of Tolterodine, Intermediates And Metabolites App 20130197082 - Sterk; Damjan | 2013-08-01 |
Synthesis of statins Grant 8,471,045 - Casar , et al. June 25, 2 | 2013-06-25 |
Catalyzed carbonylation in the synthesis of angiotensin II antagonists Grant 8,445,693 - Casar , et al. May 21, 2 | 2013-05-21 |
Pure vancomycin hydrochloride Grant 8,435,938 - Grahek , et al. May 7, 2 | 2013-05-07 |
2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists Grant 8,410,285 - Copar , et al. April 2, 2 | 2013-04-02 |
((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylate and process for the production thereof Grant 8,404,870 - Cluzeau , et al. March 26, 2 | 2013-03-26 |
Pharmaceutical Compositions Comprising A Combination Of Metformin And Sitagliptin App 20130059002 - Smrdel; Polona ;   et al. | 2013-03-07 |
Selenium containing modifying agents and conjugates Grant 8,389,695 - Kunstelj , et al. March 5, 2 | 2013-03-05 |
Process for the preparation of amorphous calcium salt of atorvastatin Grant 8,367,848 - Antoncic , et al. February 5, 2 | 2013-02-05 |
Process for the preparation of esomeprazole magnesium in a stable form Grant 8,362,259 - Toplak Casar January 29, 2 | 2013-01-29 |
Processes For The Preparation Of Key Intermediate For The Synthesis Of Rosuvastatin Or Pharmaceutically Acceptable Salts Thereof App 20130018065 - Andrensek; Samo ;   et al. | 2013-01-17 |
Process for the synthesis of rosuvastatin calcium Grant 8,354,530 - Zlicar January 15, 2 | 2013-01-15 |
Crystal form of cabergoline Grant 8,338,445 - Ham , et al. December 25, 2 | 2012-12-25 |
Process For Preparation Of Tacrolimus App 20120295316 - Petkovic; Hrvoje ;   et al. | 2012-11-22 |
Process for the preparation of methyl ester of rosuvastatin Grant 8,309,719 - Bastarda , et al. November 13, 2 | 2012-11-13 |
Process for the synthesis of HMG-CoA reductase inhibitors Grant 8,269,001 - Casar September 18, 2 | 2012-09-18 |
NEW SYNTHETIC ROUTE FOR THE PREPARATION OF ALPHA-AMINO BORONIC ACID DERIVATIVES via SUBSTITUTED ALK-1-YNES App 20120231993 - Gazic Smilovic; Ivana ;   et al. | 2012-09-13 |
Process For Hydrogenation Of Halogenoalkenes Without Dehalogenation App 20120220794 - Gazic Smilovic; Ivana ;   et al. | 2012-08-30 |
Process for solvent removal from omeprazole salts Grant 8,247,567 - Mandic , et al. August 21, 2 | 2012-08-21 |
Crystalline solvate of omeprazole sodium Grant 8,247,566 - Savanovic , et al. August 21, 2 | 2012-08-21 |
Synthesis Of Statins App 20120196333 - CASAR; ZDENKO ;   et al. | 2012-08-02 |
Process for the preparation of pure irbesartan Grant 8,212,051 - Selic July 3, 2 | 2012-07-03 |
Process for preparing pure amorphous rosuvastatin calcuim Grant 8,207,333 - Casar , et al. June 26, 2 | 2012-06-26 |
Process For Dimethylation Of Active Methylene Groups App 20120149895 - Jenko; Branko ;   et al. | 2012-06-14 |
Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-N-alkyl-3-phenylpropylamines Grant 8,193,391 - Fischer June 5, 2 | 2012-06-05 |
Process For The Preparation Of A Pharmaceutical Composition Comprising Ezetimibe App 20120135976 - Kerc; Janez ;   et al. | 2012-05-31 |
Synthesis of statins Grant 8,183,397 - Casar , et al. May 22, 2 | 2012-05-22 |
Active Pharmaceutical Ingredient Adsorbed On Solid Support App 20120088774 - Grahek; Rok ;   et al. | 2012-04-12 |
Pharmaceutical Compositions Of Active Pharmaceutical Ingredient Comprising Sulphonylurea Moiety With Excellent Dissolution Properties App 20120087953 - Reven; Sebastjan ;   et al. | 2012-04-12 |
Synthesis Of 1-(2,3-dihydrobenzofuran-4-yl)ethanone As Intermediate In The Preparation Of Ramelteon App 20120083526 - CLuzeau; Jerome | 2012-04-05 |
Novel Salts Of Sitagliptin App 20120077760 - Selic; Lovro ;   et al. | 2012-03-29 |
Synthesis Of (s)-n-[2-(1,6,7,8-tetrahydro-2h-indeno-[5,4-b]furan-8-yl)ethyl]propionami- De App 20120071673 - Cluzeau; Jerome | 2012-03-22 |
Pharmaceutical Composition Comprising Ezetimibe And Simvastatin App 20120027854 - Homar; Miha ;   et al. | 2012-02-02 |
Controlled Release Pharmaceutical Compositions Comprising O-desmethyl-venlafaxine App 20120027857 - Abramovic; Zrinka ;   et al. | 2012-02-02 |
Key Intermediates For The Synthesis Of Rosuvastatin Or Pharmaceutically Acceptable Salts Thereof App 20120022091 - Casar; Zdenko ;   et al. | 2012-01-26 |
Mammalian Expression Vector App 20110306090 - Francky; Andrej ;   et al. | 2011-12-15 |
New Crystal Form Of Sunitinib Malate App 20110275690 - Selic; Lovro | 2011-11-10 |
Sirolimus formulation Grant 8,053,444 - Reven , et al. November 8, 2 | 2011-11-08 |
Novel Ezetimibe Formulations App 20110262497 - Injac; Rade ;   et al. | 2011-10-27 |
Process For The Preparation Or Purification Of Olmesartan Medoxomil App 20110263666 - Pirc; Samo ;   et al. | 2011-10-27 |
Oxidative degradation products of atorvastatin calcium Grant 8,044,086 - Grahek , et al. October 25, 2 | 2011-10-25 |
Process For The Preparation Of Olmesartan Medoxomil App 20110224271 - Toplak Casar; Renata | 2011-09-15 |
Synthesis Of 6,7-dihydro-1h-indeno[5, 4-b] Furan-8(2h)-one As Intermediate In The Preparation Of Remelteon App 20110184058 - Cluzeau; Jerome | 2011-07-28 |
Process For The Preparation Of Methyl Ester Of Rosuvastatin App 20110184172 - Bastarda; Andrej ;   et al. | 2011-07-28 |
Synthesis Of Statins App 20110178295 - Casar; Zdenko ;   et al. | 2011-07-21 |
Use Of Inhibitor Of Beta-lactamases And Its Combination With Beta-lactam Antibiotics App 20110172200 - Prezelj; Andrej ;   et al. | 2011-07-14 |
New Trinem Antibiotics And Inhibitors Of Beta-lactamases App 20110166118 - Plantan; Ivan ;   et al. | 2011-07-07 |
Synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'-hydroxymethylbiphenyl and its use in preparation of angiotensin II antagonists Grant 7,968,727 - Copar , et al. June 28, 2 | 2011-06-28 |
Granulation Of Active Pharmaceutical Ingredients App 20110136883 - Injac; Rade ;   et al. | 2011-06-09 |
Ezetimibe Process And Composition App 20110130378 - Selic; Lovro | 2011-06-02 |
Tablet Comprising Eprosartan Mesylate App 20110112160 - Legen; Igor ;   et al. | 2011-05-12 |
Self-microemulsifying Systems Incorporated Into Liquid Core Microcapsules App 20110111042 - Kerc; Janez ;   et al. | 2011-05-12 |
2'-halobiphenyl-4-yl Intermediates In The Synthesis Of Angiotensin Ii Antagonists App 20110105539 - Copar; Anton ;   et al. | 2011-05-05 |
Catalyzed Carbonylation In The Synthesis Of Angiotensin Ii Antagonists App 20110098329 - Casar; Zdenko ;   et al. | 2011-04-28 |
Selenium Containing Modifying Agents And Conjugates App 20110092420 - Kunstelj; Menci ;   et al. | 2011-04-21 |
Process for the preparation of crystalline perindopril Grant 7,923,570 - Jenko , et al. April 12, 2 | 2011-04-12 |
Preparation Of Nanoparticles By Using A Vibrating Nozzle Device App 20110068497 - Ahlin Grabnar; Pegi ;   et al. | 2011-03-24 |
Pharmaceutical composition comprising an active principal and sulphobetaine Grant 7,906,109 - Menart , et al. March 15, 2 | 2011-03-15 |
((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl Carboxylate And Process For The Production Thereof App 20110046375 - Cluzeau; Jerome ;   et al. | 2011-02-24 |
Controlled Release Tamsulosin Hydrochloride Tablets And A Process Of Making Them App 20110033534 - Kerc; Janez ;   et al. | 2011-02-10 |
Method of preparing stabilized pharmaceutical compositions comprising active ingredients susceptible to conversion to alternate polymorph forms App 20110021631 - SVETE; Peter | 2011-01-27 |
S-omeprazole magnesium Grant 7,875,723 - Savanovic , et al. January 25, 2 | 2011-01-25 |
Duloxetin Composition App 20110008439 - Jaklic; Miha Tomaz ;   et al. | 2011-01-13 |
Self-microemulsifying Drug Delivery Systems App 20100331356 - Legen; Igor ;   et al. | 2010-12-30 |
Active Pharmaceutical Ingredient On A Solid Support, Amorphous And With An Improved Solubility App 20100305087 - Grahek; Rok ;   et al. | 2010-12-02 |
Pharmaceutical Composition Comprising At Least One Active Agent And A Binder, Which Swells In An Acidic Media App 20100297227 - Legen; Igor ;   et al. | 2010-11-25 |
Process For Preparation Of 3-(2-hydroxy-5-substituted Phenyl)-n-alkyl-3-phenylpropylamines App 20100234473 - Fischer; Erik | 2010-09-16 |
Oxidative Degeneration Products Of Atorvastatin Calcium App 20100219063 - GRAHEK; Rok ;   et al. | 2010-09-02 |
Gastroresistant Pharmaceutical Dosage Form Comprising N-(2-(2- Phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic Acid (lk-423) App 20100183714 - Bogataj; Marija ;   et al. | 2010-07-22 |
Hot-melt Micropellets App 20100172969 - Dreu; Rok ;   et al. | 2010-07-08 |
Crystal Form Of Cabergoline App 20100152223 - Ham; Zoran ;   et al. | 2010-06-17 |
Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate App 20100120868 - Stanic Ljubin; Tijana ;   et al. | 2010-05-13 |
S-Omeprazole Magnesium App 20100087652 - Savanovic; Lidija Vranicar ;   et al. | 2010-04-08 |
Process For Solvent Removal From Omeprazole Salts App 20100076025 - Mandic; Dejan ;   et al. | 2010-03-25 |
Oxidative Degradation Products Of Atorvastatin Calcium App 20100056605 - Grahek; Rok ;   et al. | 2010-03-04 |
Process for the preparation of compounds having an ace inhibitory action Grant 7,671,215 - Jenko March 2, 2 | 2010-03-02 |
Pharmaceutical Composition Comprising Perindopril App 20100048509 - Kovacic; Mateja ;   et al. | 2010-02-25 |
Bursting Pellets App 20100034887 - Kuhar; Polonca ;   et al. | 2010-02-11 |
Synthetic gene coding for human granulocyte-colony stimulating factor for the expression in E. coli Grant 7,655,437 - Jevsevar , et al. February 2, 2 | 2010-02-02 |
Stable Pharmaceutical Composition Comprising Granulocyte-Colony Stimulating Factor App 20100021419 - PODOBNIK; Barbara ;   et al. | 2010-01-28 |
Process For The Preparation Of Perindopril Erbumine App 20100016614 - Ham; Zoran ;   et al. | 2010-01-21 |
Process For The Preparation Of Esomeprazole Magnesium In A Stable Form App 20100016370 - Toplak Casar; Renata | 2010-01-21 |
Synthesis of 4-Bromomethyl-2'-Formylbiphenyl and 4-Bromomethyl-2'-Hydroxymethylbiphenyl and Its Use in Preparation of Giotensin II Antagonists App 20090318521 - Copar; Anton ;   et al. | 2009-12-24 |
Treatment of psychostimulant addiction Grant 7,632,843 - Krisch , et al. December 15, 2 | 2009-12-15 |
Multiple Unit Tablets App 20090291136 - Stanic Ljubin; Tijana ;   et al. | 2009-11-26 |
Stable Pharmaceutical Formulation Comprising A Hmg-coa Reductase Inhibitor App 20090264497 - Kerc; Janez | 2009-10-22 |
Pharmaceutical Composition App 20090238871 - Avanzo; Matej ;   et al. | 2009-09-24 |
Novel Process App 20090234139 - Selic; Lovro ;   et al. | 2009-09-17 |
Stable pharmaceutical composition granulocyte-colony stimulating factor Grant 7,585,496 - Podobnik , et al. September 8, 2 | 2009-09-08 |
Crystalline Solvate Of Omeprazole Sodium App 20090221646 - Savanovic; Lidija Vranicar ;   et al. | 2009-09-03 |
Coated Formulations For Tolterodine App 20090214642 - Legen; Igor ;   et al. | 2009-08-27 |
Novel Polymorph Form Of Irbesartan App 20090208573 - Antoncic; Ljubomir | 2009-08-20 |
Pharmaceutical Composition App 20090202636 - Beso; Adnan ;   et al. | 2009-08-13 |
Process For The Preparation Of Amorphous Calcium Salt Of Atorvastatin App 20090182030 - Antoncic; Ljubomir ;   et al. | 2009-07-16 |
Derivatives of pyridilethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, process for their preparation and pharmaceutical compositions containing them Grant 7,560,474 - Rode , et al. July 14, 2 | 2009-07-14 |
Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl) Methyl)-imidazole, dihydroimidazole or benzimidazloe derivatives App 20090176849 - Selic; Lovro | 2009-07-09 |
Crystalline form of omeprazole Grant 7,553,856 - Milac , et al. June 30, 2 | 2009-06-30 |
S-omeprazole magnesium Grant 7,553,857 - Vranicar Savanovic , et al. June 30, 2 | 2009-06-30 |
Synthesis of optically pure(r)-5-(2-amynopropyl)-2-methoxybenzenesulphonamide Grant 7,538,246 - Mohar May 26, 2 | 2009-05-26 |
Stable pharmaceutical composition comprising erythropoietin Grant 7,534,870 - Vukmirovic , et al. May 19, 2 | 2009-05-19 |
Process for Preparing Amorphous Rosuvastatin Calcium of Impurities App 20090111839 - Zlicar; Marko ;   et al. | 2009-04-30 |
Pharmaceutical composition App 20090093499 - Jaklic; Miha Tomaz ;   et al. | 2009-04-09 |
Modified release pharmaceutical composition Grant 7,485,322 - Kerc February 3, 2 | 2009-02-03 |
Preparation of Telmisartan Salts with Improved Solubility App 20090012140 - Antoncic; Ljubomir ;   et al. | 2009-01-08 |
Process for the Preparation of Crystalline Perindopril App 20080306135 - Jenko; Branko ;   et al. | 2008-12-11 |
Process for the Synthesis of Hmg-Coa Reductase Inhibitors App 20080300406 - Casar; Zdenko | 2008-12-04 |
Pharmaceutical composition comprising eszoplicone App 20080299193 - Jerala-Strukelj; Zdenka ;   et al. | 2008-12-04 |
Process For the Isolation and/or Purification of Proteins App 20080293924 - Menart; Viktor ;   et al. | 2008-11-27 |
Process for the Synthesis of Rosuvastatin Calcium App 20080255170 - Zlicar; Marko | 2008-10-16 |
Process for the Synthesis of Tetrazoles App 20080214637 - Antoncic; Ljubomir ;   et al. | 2008-09-04 |
New salts of HMG-CoA reductase inhibitors App 20080188552 - Pflaum; Zlatko | 2008-08-07 |
Sirolimus Formulation App 20080176888 - Reven; Sebastjan ;   et al. | 2008-07-24 |
Synthesis of 2-Methyl-4-(4-Methyl-1-Piperazinly)-10H-Thieno(2,3-B) (1,5) Benzodiazepine and Salts Thereof App 20080161557 - Mesar; Tomaz ;   et al. | 2008-07-03 |
Pharmaceutical Composition Containing Candesartan Cilexetil as Lipophilic Crystalline Substance App 20080118564 - Jerala-Strukelj; Zdenka ;   et al. | 2008-05-22 |
Amidinophenylalanine Derivatives as Thrombin Inhibitors App 20080004256 - Urleb; Uros ;   et al. | 2008-01-03 |
Amidinophenylalanine derivatives as thrombin inhibitors Grant 7,285,547 - Urleb , et al. October 23, 2 | 2007-10-23 |
Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods Grant 7,271,269 - Antoncic , et al. September 18, 2 | 2007-09-18 |
Oxidative Degradation Products of Atorvastatin Calcium App 20070208071 - Grahek; Rok ;   et al. | 2007-09-06 |
High purity amlodipine benzenesulfonate and a process for its preparation Grant 7,153,970 - Furlan , et al. December 26, 2 | 2006-12-26 |
Process for obtaining HMG-CoA reductase inhibitors of high purity Grant 7,141,602 - Grahek , et al. November 28, 2 | 2006-11-28 |
Thrombin inhibitors Grant 7,112,590 - Kikelj , et al. September 26, 2 | 2006-09-26 |
Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium Grant 7,030,151 - April 18, 2 | 2006-04-18 |
Solid pharmaceutical formulation containing lovastatin and simvastatin respectively, and its preparation Grant 6,984,399 - Pflaum , et al. January 10, 2 | 2006-01-10 |
Process for the preparation of amorphous atorvastatin Grant 6,891,047 - Pflaum May 10, 2 | 2005-05-10 |
New salts of HMG-CoA reductase inhibitors App 20050049422 - Pflaum, Zlatko | 2005-03-03 |
Salts of HMG-CoA reductase inhibitors Grant 6,838,566 - Pflaum January 4, 2 | 2005-01-04 |
Process for the obtaining of HMG-COA reductase inhibitors of high purity Grant 6,825,015 - Pflaum , et al. November 30, 2 | 2004-11-30 |
Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same Grant 6,806,290 - Pflaum , et al. October 19, 2 | 2004-10-19 |
Solid pharmaceutical formulation containing lovastatin and simvastatin respectively, and its preparation App 20040138295 - Pflaum, Zlatko ;   et al. | 2004-07-15 |
Crystalline sodium salt of pravastatin Grant 6,740,775 - Pflaum May 25, 2 | 2004-05-25 |
Solid pharmaceutical formulation containing lovastatin and simvastatin, respectively, and its preparation Grant 6,696,086 - Pflaum , et al. February 24, 2 | 2004-02-24 |
Process for obtaining HMG-CoA reductase inhibitors of high purity Grant 6,695,969 - Grahek , et al. February 24, 2 | 2004-02-24 |
Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor Grant 6,680,341 - Kerc January 20, 2 | 2004-01-20 |
Process for the preparation of amorphous atorvastatin Grant 6,613,916 - Pflaum September 2, 2 | 2003-09-02 |
New salts of HMG-CoA reductase inhibitors App 20030120086 - Pflaum, Zlatko | 2003-06-26 |
Salts of HMG-CoA reductase inhibitors Grant 6,583,295 - Pflaum June 24, 2 | 2003-06-24 |